Par Drugs and Chemicals Limited
  • Home
  • About Us
    • Corporate Profile
    • Board of Directors
    • Milestones
    • Awards and Appreciations
    • Research & Development
    • Recognitions & Certifications
  • Products
    • Magnesium Salts
      • Magnesium Hydroxide
      • Magnesium Trisilicate
      • Magnesium Carbonate
      • Light Magnesium Oxide
      •  Magnesium Oxide Heavy
      •  Magnesium Oxide USP
    • Dried Aluminum Hydroxide Gel
    • Blended
      • Magaldrate
      • Magnesium Aluminium Silicate Hydrated
      • Alma Gate
      • Hydrotelcite
      • Aluminium Hydroxide Magnesium Carbonate Co-Dried Gel
      • Aluminium Magnesium Silicate BP
    • Sodium Aluminium Silicate
    • Precipitated Silica
    • Magnesium Silicate
    • Amorphous
    • Collodial Silicon Dioxide
    • Sucralfate USP
  • Manufacturing
    • Registered Office
    • Manufacturing Site
    • Laboratory
  • Investors
    • Announcement & Notice
    • Investor Contact
    • Financials
      • Sales Profile
      • 10 Year's Highlight
      • Financial Statements
    • Annual Reports & Retuns
    • Corporate Governance Report
    • Share Holding Pattern
    • Compliance Certificate
    • Secretarial Compliance Report
    • Committee
    • Grievance Redressal
    • Familiarisation Programme
    • Dividend
    • Policies
    • CSR
  • Inquiry
  • Contact Us
  • Prospectus
    • Prospectus
Sitemap

Financial Statements

  • Home
  • Financial Statements

    Year 2024-25 icon icon

    • Q2. Quarterly and half year ended on 30.09.2024
    • Q1. Quarterly ended on 30.06.2024

    Year 2023-24 icon icon

    • Q4. Quarterly and Year ended on 31.03.2024
    • Q3. Quarter and nine month ended on 31.12.2023
    • Q2. Quarter and half year ended on 30.09.2023
    • Q1. Quarterly ended on 30.06.2023

    Year 2022-23 icon icon

    • Q4. Quarterly and Year ended on 31.03.2023
    • Q3. Quarterly and Nine Month ended on 31.12.2022
    • Q2.Quarterly and half year ended on 30.09.2022
    • Q1. Quarterly financial results for the quarter ended 30.06.2022

    Year 2021-22 icon icon

    • Audited Financial Results for the Quarter and Year Ended 31.03.2022
    • Quarter and Nine month Ended 31.12.2021 for F.Y. 2021-22
    • Quarterly and Half yearly Limited Review Report as on 30th September, 2021 for F.Y. 2021-22

    Year 2020-21 icon icon

    • Half Yearly & year ended Report as on 31.03.2021 for F.Y. 2020-21
    • Half Yearly Limited Review Report as on 30.09.2020 F.Y. 2020-21

    Year 2019-20 icon icon

    • Half Yearly & year ended Report as on 31.03.2020 for F.Y. 2019-20
    • Half Yearly Limited Review Report as on 30/09/2019 for F.Y. 2019-20

Investors

  •  Announcement & Notice
  •  Investor's Contact
  •  Financials
    •  Sales Profile
    • 10 Year's Highlight
    • Financial Statements
  •  Annual Reports & Retuns
  •  Corporate Governance Report
  •  Secretarial Compliance Report
  •  Share Holding Pattern
  •  Compliance Certificate
  •  Committee
  •  Grievance Redressal
  •  Familiraisation Programme
  •  Dividend
  •  Policies
  •  CSR
    • CSR Policy
    • CSR

Copyright © Par Drugs and Chemical Limited 2019. All rights reserved.

Created by: PixelWorks Web Design